Product identification
Medicine name:
Masivet 150 mg - Film-coated tablet
Active substance:
- Masitinib mesilate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Masitinib mesilate178.90milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QL01XE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Packaging:Bottle (HDPE), Package_size:30 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- CENTRE SPECIALITES PHARMACEUTIQUES
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Documents
Combined File of all Documents
English (PDF)
Download Published on: 15/11/2022
Bulgarian (PDF)
Published on: 15/11/2022
Croatian (PDF)
Published on: 15/11/2022
Czech (PDF)
Published on: 15/11/2022
Danish (PDF)
Published on: 15/11/2022
Dutch (PDF)
Published on: 15/11/2022
Estonian (PDF)
Published on: 15/11/2022
Finnish (PDF)
Published on: 15/11/2022
French (PDF)
Published on: 15/11/2022
German (PDF)
Published on: 15/11/2022
Greek (PDF)
Published on: 15/11/2022
Hungarian (PDF)
Published on: 15/11/2022
Italian (PDF)
Published on: 15/11/2022
Latvian (PDF)
Published on: 15/11/2022
Lithuanian (PDF)
Published on: 15/11/2022
Maltese (PDF)
Published on: 15/11/2022
Polish (PDF)
Published on: 15/11/2022
Portuguese (PDF)
Published on: 15/11/2022
Romanian (PDF)
Published on: 15/11/2022
Slovak (PDF)
Published on: 15/11/2022
Slovenian (PDF)
Published on: 15/11/2022
Spanish (PDF)
Published on: 15/11/2022
Swedish (PDF)
Published on: 15/11/2022
ema-puar-masivet-v-128-par-en.pdf
English (PDF)
Download Published on: 15/03/2023
How useful was this page?: